71
TITLE: Selective Interleukin-23 p19 Inhibition: Another Game Changer in Psoriasis? Focus on Risankizumab  Full Text
AUTHORS: Torres, T;
PUBLISHED: 2017, SOURCE: DRUGS, VOLUME: 77, ISSUE: 14
INDEXED IN: WOS CrossRef: 24
IN MY: ORCID
72
TITLE: Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases
AUTHORS: Pereira, R; Faria, R; Lago, P; Torres, T;
PUBLISHED: 2017, SOURCE: CURRENT DRUG SAFETY, VOLUME: 12, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 6
IN MY: ORCID
73
TITLE: Erythematous, Scaly Rash After Sun Exposure
AUTHORS: Rita S Matos; Tiago Torres;
PUBLISHED: 2017, SOURCE: AMERICAN FAMILY PHYSICIAN, VOLUME: 96, ISSUE: 9
INDEXED IN: WOS
74
TITLE: Pediatric Psoriasis
AUTHORS: Maria Relvas; Tiago Torres;
PUBLISHED: 2017, SOURCE: AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, VOLUME: 18, ISSUE: 6
INDEXED IN: WOS
75
TITLE: Atopic Dermatitis: The New Therapeutic Revolution in Dermatology  Full Text
AUTHORS: Tiago Torres;
PUBLISHED: 2017, SOURCE: ACTA MEDICA PORTUGUESA, VOLUME: 30, ISSUE: 10
INDEXED IN: WOS
77
78
TITLE: Methyl-triclosan and triclosan impact embryonic development of Danio rerio and Paracentrotus lividus  Full Text
AUTHORS: Sofia Macedo; Tiago Torres; Miguel M Santos ;
PUBLISHED: 2017, SOURCE: ECOTOXICOLOGY, VOLUME: 26, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 41
79
TITLE: Erythematous, Scaly Rash After Sun Exposure
AUTHORS: Matos, RS; Torres, T;
PUBLISHED: 2017, SOURCE: American family physician, VOLUME: 96, ISSUE: 9
INDEXED IN: Scopus
80
TITLE: Importance of immunogenicity testing for cost-effective management of psoriasis patients treated with adalimumab
AUTHORS: Fernando Mota; Esmeralda Neves; José Carlos Oliveira ; Manuela Selores; Tiago Torres;
PUBLISHED: 2017, SOURCE: Acta Dermatovenerologica Alpina, Pannonica et Adriatica, VOLUME: 26, ISSUE: 2
INDEXED IN: Scopus CrossRef: 1
IN MY: ORCID
Page 8 of 19. Total results: 185.